van Hof A C, Ubachs J M, van Wersch J W
Department of Gynaecology, De Wever Hospital, Heerlen, The Netherlands.
Haemostasis. 1992;22(3):160-4. doi: 10.1159/000216314.
The slide test method of Velaskar and Chitre for determining platelet aggregation in whole blood after induction of aggregation was modified for spontaneous platelet aggregation and evaluated. The reproducibility was satisfactory (CV 1-3%). The results obtained with this method and the method of Velaskar were not significantly different. The Spearman rank correlation was 0.75 (p less than 0.0001). We established reference values for the particle counter method and Velaskar's method in pregnant and non-pregnant women; no significant change in spontaneous platelet aggregation was seen throughout pregnancy. In order to estimate the clinical value of the test in pregnancy, we followed up a number of pregnant patients with primary enhanced spontaneous whole-blood platelet aggregation before and after treatment with low-dose acetylsalicylic acid. The test was found to be suited for the detection of spontaneous whole-blood platelet aggregation and for the follow-up after treatment with acetylsalicylic acid. Further studies are necessary, however, to assess the predictive value of an aberrant test result during pregnancy.
对Velaskar和Chitre用于测定诱导聚集后全血中血小板聚集的玻片试验方法进行了修改,以用于自发性血小板聚集并进行了评估。其重现性令人满意(变异系数为1-3%)。用该方法和Velaskar方法获得的结果无显著差异。Spearman等级相关性为0.75(p小于0.0001)。我们确定了孕妇和非孕妇使用血细胞计数器法和Velaskar方法的参考值;整个孕期自发性血小板聚集未见明显变化。为了评估该试验在孕期的临床价值,我们对一些原发性全血自发性血小板聚集增强的孕妇在低剂量乙酰水杨酸治疗前后进行了随访。发现该试验适用于检测自发性全血血小板聚集以及乙酰水杨酸治疗后的随访。然而,需要进一步研究以评估孕期异常试验结果的预测价值。